Evaluation of the efficacy of carotenoid drugs in age-related macular degeneration

The aim of the study was clinical and functional assessment of the effectiveness of the drug "Lutein Ophthalmo" in treatment of age-related macular degeneration . We observed 40 patients (80 eyes ) aged from 55 till 80 years , with the age- related macular degeneration , which were divided into 2 groups. The first group (control ) - 20 people (40 eyes) who received conventional therapy . The second group ( basic) - 20 people ( 40 eyes ) who received conventional treatment in addition to the preparation of 500 mg "Lutein Ophthalmo" leap x 2 times daily for 30 days. During the spent treatment in the basic group of patients visual acuity improvement, reduction relative scotomas and with preservation of a condition of a retina of stable effect is noted indicators. All of this allows us to recommend "Lutein Ophthalmo" in treatment age-related macular degeneration